Latest News

The World Heart Federation (WHF) proudly represented the global cardiovascular community at the Seventy-Eighth World Health Assembly (WHA78), which concluded on 27 May 2025 in Geneva, Switzerland.   Throughout the Health Assembly, WHF delivered a series of high-impact statements across a range of agenda items to ensure that cardiovascular health remains central to global health priorities, […]

This statement was delivered by the World Heart Federation under agenda item 13.9 – Global Strategy for Women’s, Children’s, and Adolescents’ Health – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, The World Heart Federation applauds the Director-General for his report and welcomes the newly released guidelines on rheumatic heart disease – […]

This constituency statement was led by NCD Alliance and the World Heart Federation under agenda item 13.3 – Universal Health Coverage – at the Seventy-Eighth World Health Assembly. Distinguished delegates, There can be no Universal Health Coverage without addressing noncommunicable diseases and mental health – these are central to efforts to realise UHC. Yet, […]

This statement was delivered under agenda item 18.3 – Climate change and health – at the Seventy-Eighth World Health Assembly by the World Heart Federation on behalf of: NCD Alliance Union for International Cancer Control Alzheimer’s Disease International HelpAge International Humatem World Stroke Organization International Alliance of Patients’ Organizations (IAPO) International Society of Nephrology International […]

This statement was delivered by the World Heart Federation under agenda item 18.1 – The impact of chemicals, waste, and pollution on human health– at the seventy-eighth world health assembly. Honourable Chair, Distinguished Delegates, The World Heart Federation welcomes the Director-General’s report and commends Member States for recognizing pollution, especially lead pollution, as a major […]

This statement was delivered by the World Heart Federation under agenda item 13.5 – Substandard and Falsified Medical Products – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, The World Heart Federation, supported by the Fight the Fakes Alliance, welcomes the independent evaluation of the Member State Mechanism on Substandard and Falsified Medical […]

This statement was delivered by the World Heart Federation under agenda item 13.1 – Noncommunicable Diseases – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, The World Heart Federation urges bold political action to address cardiovascular disease – the world’s leading, yet most preventable, health threat. WHF calls on Member States to prioritize […]

This statement was delivered by the World Heart Federation under agenda item 17.1 – WHO’s Work in Health Emergencies – at the Seventy-Eighth World Health Assembly. Honourable Chair, Distinguished Delegates, People Living with Noncommunicable Diseases, particularly cardiovascular disease and diabetes, face significant challenges in emergency settings due to strained health systems and disrupted services. […]

GENEVA, 17 May 2025: Stigma and misunderstanding of obesity are preventing people from receiving adequate treatment for the disease, which is increasing the risk of cardiovascular disease (CVD), a new report from the World Heart Federation warns today. The “World Heart Report 2025 – Obesity and Cardiovascular Disease” launched at the World Heart Summit today, […]

Professor Prabhakaran Dorairaj is the Executive Director of the Centre for Chronic Disease Control, New Delhi, a Distinguished Professor of the Public Health Foundation of India and President-Elect of the World Heart Federation. He spoke about receiving the “Excellence Award for Hypertension Risk Reduction,” his belief in a better future addressing a condition that caused […]

Homozygous Familial Hypercholesterolemia (HoFH) is a rare inherited condition that causes dangerously high levels of LDL cholesterol from birth, leading to severe cardiovascular complications and early mortality. Despite affecting approximately 1 in 300,000 people worldwide, fewer than 5% of individuals with HoFH receive an accurate and timely diagnosis. Without intervention, children with HoFH often show […]